CETIRIZINE HYDROCHL
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
Defense Logistics Agency award SPE2DP25F9532 was issued to DMS Pharmaceutical Group Inc under delivery order SPE2DX15D9383 for the procurement of Cetirizine Hydrochl, identified by NSN 6505014271064. The overarching commercial items contract SPE2DX-15-D-9383 carries a total award amount of 4,999,999.00 dollars and incorporates standard FAR clauses regarding defense priority and transportation instructions. Despite the initial award, modification P00001 issued by DLA Troop Support on July 12, 2025, resulted in the cancellation of CLIN 0001. This bilateral modification was executed for the governments convenience because the associated ship is decommissioning in September 2026, rendering the material unnecessary. Consequently, the total contract amount for this specific order was reduced from 4.96 dollars to 0.00 dollars at no cost to the government.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
